Loading...
ANIX Anixa Biosciences
No Data
News
Comment
Anixa Biosciences (NASDAQ:ANIX) Is In A Strong Position To Grow Its Business
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although software-as-a-service business Salesforce.com l
Anixa Biosciences to Present at the 2022 H.C. Wainwright Global Investment Conference
PRNewswire 5-May-2022 8:30 AMSAN JOSE, Calif., May 5, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on the treatment and prevention of cancer and infecti
12 Health Care Stocks Moving In Friday's Intraday Session
 Gainers Vaxxinity (NASDAQ:VAXX) stock moved upwards by 45.9% to $5.5 during Friday's regular session. Trading volume for this security as of 13:30 EST is 12.1 million, which is 15165.5% of its aver
ANIX and CPS among mid-day movers
Gainers: GTY Technology Holdings (GTYH) +114%.Vaxxinity (VAXX) +57%.Zymeworks (ZYME) +35%.Redbox Entertainment (RDBX) +33%.Finch Therapeutics Group (FNCH) +29%.Opiant Pharmaceuticals (OPNT) +29%.Puyi
Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
SAN JOSE, Calif., April 28, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced a presentation outlining the design of its breast c
3 Stocks Under $3 Insiders Are Aggressively Buying
US crude oil futures traded lower on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the co
Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at The 4th International Workshop on CAR-T 2022
SAN JOSE, Calif., April 6, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today annou
Analysts Offer Insights on Healthcare Companies: Alaunos Therapeutics (TCRT), Anixa Biosciences (ANIX) and Autolus Therapeutics (AUTL)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alaunos Therapeutics (TCRT – Research Report), Anixa Biosciences (ANIX – Research Report) and Autolus
Anixa Biosciences Starts Early-Stage CAR-T Trial in Ovarian Cancer
03:02 PM EDT, 03/30/2022 (MT Newswires) -- Anixa Biosciences (ANIX) said Wednesday it has launched a phase 1 clinical study of its chimeric antigen receptor T-cell, or CAR-T, therapy in ovarian cancer
Anixa Biosciences initiates phase 1 trial of its ovarian cancer CAR-T therapy
Biotechnology company Anixa Biosciences (NASDAQ:ANIX +1.6%) initiated a phase 1 trial evaluating its CAR-T therapy in ovarian cancer. The early-stage trial will be held at Moffitt Cancer Center and wi